Selected research
Industry Research
Lysophosphatidic Acid Receptor 1 Industry Research Report 2026
Market perspective
The global Lysophosphatidic Acid Receptor 1 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lysophosphatidic Acid Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lysophosphatidic Acid Receptor 1 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lysophosphatidic Acid Receptor 1 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lysophosphatidic Acid Receptor 1 include Sanofi, Ube Industries Ltd, RxBio Inc, Ono Pharmaceutical Co Ltd, F. Hoffmann-La Roche Ltd, Epigen Biosciences Inc and Bristol-Myers Squibb Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lysophosphatidic Acid Receptor 1 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lysophosphatidic Acid Receptor 1 Market by Company
Sanofi
Ube Industries Ltd
RxBio Inc
Ono Pharmaceutical Co Ltd
F. Hoffmann-La Roche Ltd
Epigen Biosciences Inc
Bristol-Myers Squibb Co
Lysophosphatidic Acid Receptor 1 Segment by Type
BMS-986020
BMS-986202
Rx-100
SAR-100842
Others
Lysophosphatidic Acid Receptor 1 Segment by Application
Metabolic Disorders
Diarrhea
Kidney Fibrosis
Oncology
Others
Lysophosphatidic Acid Receptor 1 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysophosphatidic Acid Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lysophosphatidic Acid Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysophosphatidic Acid Receptor 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lysophosphatidic Acid Receptor 1 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lysophosphatidic Acid Receptor 1 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lysophosphatidic Acid Receptor 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- BMS-986020
- BMS-986202
- Rx-100
- SAR-100842
- Others
Applications
- Metabolic Disorders
- Diarrhea
- Kidney Fibrosis
- Oncology
- Others
Companies covered
- Sanofi
- Ube Industries Ltd
- RxBio Inc
- Ono Pharmaceutical Co Ltd
- F. Hoffmann-La Roche Ltd
- Epigen Biosciences Inc
- Bristol-Myers Squibb Co
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lysophosphatidic Acid Receptor 1 Market Size (2021-2032)
- 2.2.2 Global Lysophosphatidic Acid Receptor 1 Sales (2021-2032)
- 2.2.3 Global Lysophosphatidic Acid Receptor 1 Market Average Price (2021-2032)
- 2.3 Lysophosphatidic Acid Receptor 1 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 BMS-986020
- 2.3.3 BMS-986202
- 2.3.4 Rx-100
- 2.3.5 SAR-100842
- 2.3.6 Others
- 2.4 Lysophosphatidic Acid Receptor 1 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Metabolic Disorders
- 2.4.3 Diarrhea
- 2.4.4 Kidney Fibrosis
- 2.4.5 Oncology
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lysophosphatidic Acid Receptor 1 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lysophosphatidic Acid Receptor 1 Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Lysophosphatidic Acid Receptor 1 Revenue of Manufacturers (2021-2026)
- 3.4 Global Lysophosphatidic Acid Receptor 1 Average Price by Manufacturers (2021-2026)
- 3.5 Global Lysophosphatidic Acid Receptor 1 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lysophosphatidic Acid Receptor 1, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lysophosphatidic Acid Receptor 1, Product Type & Application
- 3.8 Global Manufacturers of Lysophosphatidic Acid Receptor 1, Established Date
- 3.9 Global Lysophosphatidic Acid Receptor 1 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Ube Industries Ltd
- 4.2.1 Ube Industries Ltd Company Information
- 4.2.2 Ube Industries Ltd Business Overview
- 4.2.3 Ube Industries Ltd Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ube Industries Ltd Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.2.5 Ube Industries Ltd Recent Developments
- 4.3 RxBio Inc
- 4.3.1 RxBio Inc Company Information
- 4.3.2 RxBio Inc Business Overview
- 4.3.3 RxBio Inc Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 RxBio Inc Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.3.5 RxBio Inc Recent Developments
- 4.4 Ono Pharmaceutical Co Ltd
- 4.4.1 Ono Pharmaceutical Co Ltd Company Information
- 4.4.2 Ono Pharmaceutical Co Ltd Business Overview
- 4.4.3 Ono Pharmaceutical Co Ltd Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ono Pharmaceutical Co Ltd Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.4.5 Ono Pharmaceutical Co Ltd Recent Developments
- 4.5 F. Hoffmann-La Roche Ltd
- 4.5.1 F. Hoffmann-La Roche Ltd Company Information
- 4.5.2 F. Hoffmann-La Roche Ltd Business Overview
- 4.5.3 F. Hoffmann-La Roche Ltd Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 F. Hoffmann-La Roche Ltd Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.5.5 F. Hoffmann-La Roche Ltd Recent Developments
- 4.6 Epigen Biosciences Inc
- 4.6.1 Epigen Biosciences Inc Company Information
- 4.6.2 Epigen Biosciences Inc Business Overview
- 4.6.3 Epigen Biosciences Inc Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Epigen Biosciences Inc Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.6.5 Epigen Biosciences Inc Recent Developments
- 4.7 Bristol-Myers Squibb Co
- 4.7.1 Bristol-Myers Squibb Co Company Information
- 4.7.2 Bristol-Myers Squibb Co Business Overview
- 4.7.3 Bristol-Myers Squibb Co Lysophosphatidic Acid Receptor 1 Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bristol-Myers Squibb Co Lysophosphatidic Acid Receptor 1 Product Portfolio
- 4.7.5 Bristol-Myers Squibb Co Recent Developments
5 Global Lysophosphatidic Acid Receptor 1 Market Scenario by Region
- 5.1 Global Lysophosphatidic Acid Receptor 1 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lysophosphatidic Acid Receptor 1 Sales by Region: 2021-2032
- 5.2.1 Global Lysophosphatidic Acid Receptor 1 Sales by Region: 2021-2026
- 5.2.2 Global Lysophosphatidic Acid Receptor 1 Sales by Region: 2027-2032
- 5.3 Global Lysophosphatidic Acid Receptor 1 Revenue by Region: 2021-2032
- 5.3.1 Global Lysophosphatidic Acid Receptor 1 Revenue by Region: 2021-2026
- 5.3.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Region: 2027-2032
- 5.4 North America Lysophosphatidic Acid Receptor 1 Market Facts & Figures by Country
- 5.4.1 North America Lysophosphatidic Acid Receptor 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lysophosphatidic Acid Receptor 1 Sales by Country (2021-2032)
- 5.4.3 North America Lysophosphatidic Acid Receptor 1 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lysophosphatidic Acid Receptor 1 Market Facts & Figures by Country
- 5.5.1 Europe Lysophosphatidic Acid Receptor 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lysophosphatidic Acid Receptor 1 Sales by Country (2021-2032)
- 5.5.3 Europe Lysophosphatidic Acid Receptor 1 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lysophosphatidic Acid Receptor 1 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lysophosphatidic Acid Receptor 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lysophosphatidic Acid Receptor 1 Market Facts & Figures by Country
- 5.7.1 South America Lysophosphatidic Acid Receptor 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lysophosphatidic Acid Receptor 1 Sales by Country (2021-2032)
- 5.7.3 South America Lysophosphatidic Acid Receptor 1 Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lysophosphatidic Acid Receptor 1 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lysophosphatidic Acid Receptor 1 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lysophosphatidic Acid Receptor 1 Sales by Type (2021-2032)
- 6.1.1 Global Lysophosphatidic Acid Receptor 1 Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2021-2032)
- 6.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Type (2021-2032)
- 6.2.1 Global Lysophosphatidic Acid Receptor 1 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2021-2032)
- 6.3 Global Lysophosphatidic Acid Receptor 1 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lysophosphatidic Acid Receptor 1 Sales by Application (2021-2032)
- 7.1.1 Global Lysophosphatidic Acid Receptor 1 Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2021-2032)
- 7.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Application (2021-2032)
- 7.2.1 Global Lysophosphatidic Acid Receptor 1 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2021-2032)
- 7.3 Global Lysophosphatidic Acid Receptor 1 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lysophosphatidic Acid Receptor 1 Value Chain Analysis
- 8.1.1 Lysophosphatidic Acid Receptor 1 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lysophosphatidic Acid Receptor 1 Production Mode & Process
- 8.2 Lysophosphatidic Acid Receptor 1 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lysophosphatidic Acid Receptor 1 Distributors
- 8.2.3 Lysophosphatidic Acid Receptor 1 Customers
9 Global Lysophosphatidic Acid Receptor 1 Analyzing Market Dynamics
- 9.1 Lysophosphatidic Acid Receptor 1 Industry Trends
- 9.2 Lysophosphatidic Acid Receptor 1 Industry Drivers
- 9.3 Lysophosphatidic Acid Receptor 1 Industry Opportunities and Challenges
- 9.4 Lysophosphatidic Acid Receptor 1 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst